Study reveals a novel biomarker, potentially improved therapy for MS and related neurodegenerative disorders

Degeneration of myelin, an insulating sheath required for rapid communication between nerve cells, and neuroinflammation are notable hallmarks of Multiple Sclerosis (MS) and related neurodegenerative disorders such as Alzheimer’s disease and Huntington’s disease, which affect roughly 2.8 million people in the world. However, little is known about the precise molecular steps by which demyelination leads to the loss of neurons and glia, the two major types of brain cells.

Leave A Comment

Your email address will not be published. Required fields are marked *